ATC Group: A06AD11 Lactulose

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A06AD11 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Laxatives
3
Laxatives
4
Osmotically acting laxatives
5
A06AD11
Lactulose

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
6.7 g

Active ingredients in A06AD11

Active Ingredient
Description

Lactulose is a synthetic disaccharide which is metabolised by gastro-intestinal bacterial flora to low molecular weight acids (chiefly lactic and acetic acids). There is no endogenous metabolising enzyme in the human gut. Its mode of action in constipation is as an osmotic agent producing soft stools.

Medicines in this ATC group

Drug
Countries

Hong Kong

South Africa

Ecuador

Germany South Africa

United States

Hong Kong

Hong Kong Singapore

Austria Brazil Cyprus Ecuador Estonia ...

South Africa

Ecuador

Brazil

Lithuania

Ecuador

Brazil

New Zealand

South Africa

Singapore

Singapore

Austria

Austria France Ireland New Zealand

Tunisia

Netherlands

South Africa

Ireland

Ecuador

Finland

Hong Kong

Hong Kong

Ecuador

Tunisia

Ecuador

Ecuador

Related product monographs

Title
Type
Country
Structured Product Labeling (SPL)
US
Summary of Product Characteristics (SPC)
IE
Summary of Product Characteristics (SPC)
IE